CRH
CRH | NYSE
$96.68
+$5.87 (+6.46%)
Nov 2, 2026, 11:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 37.45B | 35.57B | 34.95B | 32.72B | 30.98B | 27.59B |
Cost of Revenue | 23.92B | 22.87B | 22.99B | 21.84B | 20.49B | 18.43B |
Gross Profit | 13.53B | 12.7B | 11.96B | 10.88B | 10.49B | 9.16B |
Operating Income | 5.44B | 4.93B | 4.19B | 3.89B | 3.59B | 2.26B |
Interest Income | 146M | 143M | 206M | 65M | n/a | n/a |
Pretax Income | 4.81B | 4.71B | 4B | 3.47B | 3.34B | 1.66B |
Net Income | 3.75B | 3.49B | 3.18B | 3.85B | 2.57B | 1.12B |
Selling & General & Admin | 8.28B | 7.85B | 7.49B | 6.99B | 6.9B | 6.9B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -195M | -76M | 291M | n/a | n/a | n/a |
Operating Expenses | 8.09B | 7.78B | 7.78B | 6.99B | 6.9B | 6.9B |
Interest Expense | 810M | 612M | 376M | 401M | 311M | 389M |
Selling & Marketing Expenses | n/a | n/a | n/a | 5B | 4.85B | 4.45B |
Cost & Expenses | 32.01B | 30.65B | 30.76B | 28.83B | 27.4B | 25.32B |
Income Tax Expense | 1.04B | 1.09B | 925M | 785M | 721M | 499M |
Shares Outstanding (Basic) | 673.2M | 683.3M | 723.9M | 758.3M | 780.2M | 785.1M |
Shares Outstanding (Diluted) | 677M | 689.5M | 729.2M | 764.1M | 786.8M | 791.1M |
EPS (Basic) | 5.54 | 5.06 | 4.36 | 5.07 | 3.29 | 1.43 |
EPS (Diluted) | 5.51 | 5.02 | 4.33 | 5.03 | 3.26 | 1.42 |
EBITDA | 7.77B | 7.12B | 6.01B | 5.63B | 5.42B | 3.75B |
EBIT | 5.62B | 5.33B | 4.37B | 3.87B | 3.65B | 2.05B |
Depreciation & Amortization | 2.16B | 1.8B | 1.63B | 1.76B | 1.77B | 1.69B |
Add to Watchlist
Select watchlists to add or remove CRH